C. Masci
- Hepatology top 1%
- Hepatitis C virus research 11
- Gastroenterology top 5%
- Gastroesophageal reflux and treatments 1
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 6
- Hepatitis B Virus Studies 2
- Rheumatology top 10%
- Systemic Lupus Erythematosus Research 8
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Alcohol Consumption and Health Effects 2
-
- Diabetes and associated disorders 1
C. Masci
14 papers receiving 837 citations
Peers
Comparison fields: 5 of 54
- Hepatology 620
- Gastroenterology 169
- Epidemiology 571
- Rheumatology 116
- Surgery 176
Countries citing papers authored by C. Masci
This map shows the geographic impact of C. Masci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Masci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Masci more than expected).
Fields of papers citing papers by C. Masci
This network shows the impact of papers produced by C. Masci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Masci. The network helps show where C. Masci may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. Masci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders. | 1999 | 43 |
| 2 | 1998 | 5 | |
| 3 | 1997 | 10 | |
| 4 | Three-year follow-up of chronic hepatitis C patients treated with ribavirin plus interferon-alfa combination therapy Evidence for long-term efficacy and safety | 1996 | 1 |
| 5 | 1995 | 46 | |
| 6 | 1994 | 236 | |
| 7 | 1993 | 6 | |
| 8 | 1993 | 154 | |
| 9 | 1992 | 58 | |
| 10 | 1992 | 186 | |
| 11 | 1992 | 4 | |
| 12 | 1991 | 75 | |
| 13 | 1991 | 47 | |
| 14 | [Rare digestive hemorrhage caused by diverticular pathology of the small intestine]. | 1990 | 0 |
| 15 | 1990 | 1 |
About C. Masci
C. Masci is a scholar working on Hepatology, Rheumatology and Gastroenterology, having authored 15 papers that have together received 872 indexed citations. Recurring topics across this work include Hepatitis C virus research (11 papers), Systemic Lupus Erythematosus Research (8 papers), Liver Disease Diagnosis and Treatment (6 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Hepatitis B Virus Studies (2 papers), Alcohol Consumption and Health Effects (2 papers), Gastroesophageal reflux and treatments (1 paper) and Diabetes and associated disorders (1 paper). The work is most often cited by research in Hepatology (620 citations), Gastroenterology (169 citations) and Epidemiology (571 citations). C. Masci has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include S. Brillanti, Jeremy A. Garson, L. Barbara, M. Miglioli, Luigi Barbara, Kevin Whitby, Silvia Gaiani, Giulio Di Febo, Cesare Tosetti and Gian Maria Paganelli. Their work appears in journals such as Journal of Hepatology, Journal of Medical Virology, Gastroenterology, The Lancet and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.